Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-027942

SVP & Chief Financial Officer sold 90,000 shares at an average $84.05 ($7,564,200)

  • SVP & Chief Financial Officer acquired 90,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Labrucherie Gil M · SVP & Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2018-05-01 Exercise or conversion : show line 1 in the form +30,000 $10.69 $320,700 129,739 D
2018-05-01 Sale : show line 2 in the form −30,000 $83.65 $2,509,500 99,739 D
2018-05-02 Exercise or conversion : show line 3 in the form +30,000 $10.69 $320,700 129,739 D
2018-05-02 Sale : show line 4 in the form −30,000 $85.63 $2,568,900 99,739 D
2018-05-03 Exercise or conversion : show line 5 in the form +30,000 $10.69 $320,700 129,739 D
2018-05-03 Sale : show line 6 in the form −30,000 $82.86 $2,485,800 99,739 D
Open-market sales · 90,000 sh · avg $84.05 · $7,564,200

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2018-05-01 Exercise or conversion : show line 7 in the form Stock Option −30,000 60,000 D
2018-05-02 Exercise or conversion : show line 8 in the form Stock Option −30,000 30,000 D
2018-05-03 Exercise or conversion : show line 9 in the form Stock Option −30,000 0 D
Loading xslF345X03/doc4.xml…